Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man.
Eight male subjects were given pentagastrin by intravenous infusion in doses of 25, 74, 222, 667, and 2000 ng/kg/hr, each dose for 30 min. On another day the same subjects were given the same doses of pentagastrin while gastric inhibitory polypeptide (GIP) was being infused intravenously in a dose of 2 microgram/kg/hr. At the 222 ng/kg/hr dose of pentagastrin, acid output was significantly lower with GIP; at all other doses of pentagastrin, acid output did not differ significantly in tests with and without GIP. Pepsin output in the tests with and without GIP did not differ significantly at any dose of pentagastrin. Plasma concentration of GIP, measured by radioimmunoassay, showed a mean +/- SE plateau level of 7.4 +/- 1.4 ng/ml during GIP infusion and 0.4 +/- 0.1 ng/ml peak level after a standard meal. We conclude that the increase in blood concentration of GIP produced by feeding is probably inadequate to cause significant inhibition of gastric acid or pepsin secretion in man.
D000328:Adult; D000368:Aged; D005749:Gastric Inhibitory Polypeptide / Q000097:blood; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism*; D005768:Gastrointestinal Hormones; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D010418:Pentagastrin; D011863:Radioimmunoassay
D005768:Gastrointestinal Hormones; D005749:Gastric Inhibitory Polypeptide; D010418:Pentagastrin